These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9006320)

  • 1. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
    Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
    Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.
    Wienecke R; Maize JC; Shoarinejad F; Vass WC; Reed J; Bonifacino JS; Resau JH; de Gunzburg J; Yeung RS; DeClue JE
    Oncogene; 1996 Sep; 13(5):913-23. PubMed ID: 8806680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT; Reddy AJ; Zhang J; Gutmann DH
    Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
    Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
    Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hamartin and tuberin expression in human tissues.
    Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV
    Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of the tuberous sclerosis gene-2 product during neuronal differentiation.
    Soucek T; Hölzl G; Bernaschek G; Hengstschläger M
    Oncogene; 1998 Apr; 16(17):2197-204. PubMed ID: 9619828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
    Zhang Y; Gao X; Saucedo LJ; Ru B; Edgar BA; Pan D
    Nat Cell Biol; 2003 Jun; 5(6):578-81. PubMed ID: 12771962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
    Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
    Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.
    Mizuguchi M; Mori M; Nozaki Y; Momoi MY; Itoh M; Takashima S; Hino O
    Acta Neuropathol; 2004 Jan; 107(1):47-52. PubMed ID: 14566415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
    Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
    Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Rap1 GTPase in astrocyte growth regulation.
    Apicelli AJ; Uhlmann EJ; Baldwin RL; Ding H; Nagy A; Guha A; Gutmann DH
    Glia; 2003 May; 42(3):225-34. PubMed ID: 12673829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues.
    Menchine M; Emelin JK; Mischel PS; Haag TA; Norman MG; Pepkowitz SH; Welsh CT; Townsend JJ; Vinters HV
    Mod Pathol; 1996 Nov; 9(11):1071-80. PubMed ID: 8933518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.